SWS Hemodialysis Care Co. Ltd. A Net Assets
SWS Hemodialysis Care Co. Ltd. A net assets. Based on the latest financial reports, SWS Hemodialysis Care Co. Ltd. A (688410) has net assets worth CN¥1.71 Billion CNY (≈ $250.11 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.06 Billion ≈ $301.26 Million USD) and total liabilities (CN¥349.56 Million ≈ $51.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 688410 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.71 Billion |
| % of Total Assets | 83.02% |
| Annual Growth Rate | 46.03% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 122.92 |
Net Assets of SWS Hemodialysis Care Co. Ltd. A (2020–2024)
Net assets of SWS Hemodialysis Care Co. Ltd. A from 2020 to 2024. This chart illustrates how SWS Hemodialysis Care Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of SWS Hemodialysis Care Co. Ltd. A to measure how much of total assets are equity-financed.
Annual Net Assets for SWS Hemodialysis Care Co. Ltd. A (2020–2024)
The table below shows the annual net assets of SWS Hemodialysis Care Co. Ltd. A from 2020 to 2024. For live market cap and overall valuation, see SWS Hemodialysis Care Co. Ltd. A (688410) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.68 Billion ≈ $245.59 Million |
-1.02% |
| 2023-12-31 | CN¥1.70 Billion ≈ $248.11 Million |
+11.88% |
| 2022-12-31 | CN¥1.52 Billion ≈ $221.76 Million |
+289.15% |
| 2021-12-31 | CN¥389.43 Million ≈ $56.99 Million |
+5.52% |
| 2020-12-31 | CN¥369.05 Million ≈ $54.00 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SWS Hemodialysis Care Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24080908668.0% over the analyzed period, indicating profitable operations and earnings retention.
SWS Hemodialysis Care Co. Ltd. A Net Assets Breakdown (December 2024)
SWS Hemodialysis Care Co. Ltd. A net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥188.35 Million | 11.16% |
| Other Components | CN¥1.50 Billion | 88.84% |
| Total Equity | CN¥1.69 Billion | 100.00% |
SWS Hemodialysis Care Co. Ltd. A Competitors by Market Cap
The table below lists competitors of SWS Hemodialysis Care Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shanghai Lili & Beauty Cosmetics Co Ltd
SHG:605136
|
$506.89 Million |
|
Guangdong Piano Customized Furniture Co Ltd
SHE:002853
|
$506.95 Million |
|
Changchun Gas Co Ltd
SHG:600333
|
$507.09 Million |
|
Fujian Rongji Software Co Ltd
SHE:002474
|
$507.13 Million |
|
Invesco Municipal Trust
NYSE:VKQ
|
$506.32 Million |
|
Zhejiang Tieliu Clutch Co Ltd
SHG:603926
|
$506.27 Million |
|
Shanghai HiTech Control System
SHE:002184
|
$506.20 Million |
|
Dada Nexus Ltd
NASDAQ:DADA
|
$506.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SWS Hemodialysis Care Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,697,389,745 to 1,687,060,396, a change of -10,329,349 (-0.6%).
- Net income of 70,886,298 contributed positively to equity growth.
- Dividend payments of 43,129,617 reduced retained earnings.
- Other factors decreased equity by 38,086,030.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥70.89 Million | +4.2% |
| Dividends Paid | CN¥43.13 Million | -2.56% |
| Other Changes | CN¥-38.09 Million | -2.26% |
| Total Change | CN¥- | -0.61% |
Book Value vs Market Value Analysis
This analysis compares SWS Hemodialysis Care Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.15x to 2.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥1.51 | CN¥10.83 | x |
| 2021-12-31 | CN¥1.60 | CN¥10.83 | x |
| 2022-12-31 | CN¥4.72 | CN¥10.83 | x |
| 2023-12-31 | CN¥5.28 | CN¥10.83 | x |
| 2024-12-31 | CN¥5.25 | CN¥10.83 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SWS Hemodialysis Care Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.50%
- • Asset Turnover: 0.28x
- • Equity Multiplier: 1.19x
- Recent ROE (4.20%) is below the historical average (6.05%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 5.65% | 8.10% | 0.42x | 1.66x | CN¥-15.88 Million |
| 2021 | 5.04% | 6.87% | 0.51x | 1.44x | CN¥-19.20 Million |
| 2022 | 3.91% | 15.51% | 0.20x | 1.27x | CN¥-92.27 Million |
| 2023 | 11.46% | 28.18% | 0.36x | 1.14x | CN¥24.76 Million |
| 2024 | 4.20% | 12.50% | 0.28x | 1.19x | CN¥-97.82 Million |
Industry Comparison
This section compares SWS Hemodialysis Care Co. Ltd. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,111,929,915
- Average return on equity (ROE) among peers: 10.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SWS Hemodialysis Care Co. Ltd. A (688410) | CN¥1.71 Billion | 5.65% | 0.20x | $506.49 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.81 Billion | 2.97% | 1.05x | $419.89 Million |
| Blue Sail Medical Co Ltd (002382) | $1.30 Billion | 13.93% | 0.22x | $831.57 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $3.56 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $1.02 Billion | 24.36% | 0.86x | $778.40 Million |
| Guangzhou Improve Med Instrument (300030) | $930.46 Million | 4.28% | 0.55x | $312.18 Million |
| QITIAN Technology Group Co Ltd (300061) | $408.78 Million | 0.00% | 0.59x | $729.02 Million |
| Shanghai Tofflon Science Tech (300171) | $3.12 Billion | 2.26% | 0.50x | $1.53 Billion |
| Truking Technology Ltd (300358) | $224.96 Million | 31.22% | 1.46x | $944.90 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $978.79 Million | 15.93% | 0.44x | $734.18 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $574.90 Million | 6.24% | 0.48x | $1.30 Billion |
About SWS Hemodialysis Care Co. Ltd. A
SWS Hemodialysis Care Co., Ltd. provides integrated blood purification solutions for renal failure and critically ill patients internationally. It offers blood purification consumables, chain hemodialysis center medical services, dialysis disposables, and a dialysis center intelligent management system, as well as operates chain dialysis centers. The company also offers blood purification equipme… Read more